- Review
- Open access
- Published:
Risk factors for deep venous thrombosis following total hip arthroplasty: a meta-analysis
Thrombosis Journal volume 23, Article number: 58 (2025)
Abstract
We aim to investigate the predictors of deep venous thrombosis (DVT) following total hip arthroplasty (THA) by meta-analysis.
AbstractSection MethodsWe collected potential indicators of DVT from related literature in the English databases of PubMed, Embase, and the Cochrane Library. We used RevMan 5.3 and STATA 12.0 to analyze potential indicators of DVT after THA.
AbstractSection ResultsFinally, there were 6 English articles included in our study, and the rate of DVT after THA was 18.9% (270 of 1428 patients). Our findings indicated that advanced age [p<0.00001, OR = 4.51, 95% CI (2.91, 6.10)], female patients [p = 0.008, OR = 0.65, 95% CI (0.47, 0.89)], body mass index [p = 0.01, OR = 0.76, 95% CI (0.15, 1.37)], diabetes [p = 0.01, OR = 1.85, 95% CI (1.14, 3.01)], malignancy [p = 0.001, OR = 2.54, 95% CI (1.46, 4.41)], uncemented prosthesis[p = 0.0003, OR = 0.22, 95% CI (0.10, 0.50)], and longer operation time [p<0.00001, OR = 33.50, 95% CI (23.59, 43.41)] were predictors for DVT following THA.
AbstractSection ConclusionsMany factors were found to be associated with DVT after THA. We provided references when we met the above characteristics of patients.
Introduction
Total hip arthroplasty (THA) is mainly used to treat joint pain and dysfunction due to hip joint diseases, including hip joint osteoarthritis, femoral head necrosis, and bone neck fractures [1]. Nowadays, more than 500,000 patients globally receive THA due to hip diseases each year, and it is estimated to be up to 40% in 2030 [2,3,4]. Venous thromboembolism (VTE) is a common or even fatal complication after THA. The incidence of DVT, which is a life-threatening complication because it can lead to fatal PE, can be as high as 40–60% [5] following THA. Therefore, it is urgent to find a valid prediction of DVT during the perioperative period.
Recently, increasing number of studies have focused on this hot topic. Yu [6] found that age > 70 years old, BMI ≥ 28 kg/m2, diabetes, bilateral joint replacements, duration of surgery ≥ 120 min, cemented prosthesis, and duration of days in bed > 3 days were the risk factors of DVT after THA, while Wakabayashi [7] demonstrated that increased age, rheumatoid arthritis, and a history of major surgery were related to DVT. Although ongoing research has investigated DVT after THA, its risk factors remain poorly understood. As we know, this is the first meta-analysis to evaluate the predictors of DVT following THA.
Methods
Search strategy
Two authors searched PubMed, Embase, and Cochrane Library for titles from the inception of the database to January 2025 through an iterative process using a combination of keywords and mesh terms: “deep venous thrombosis”, “total hip arthroplasty”, AND “risk factors” OR “preditors” in the English databases, such as PubMed, Embase, and Cochrane Library. The purpose, research question, and eligibility criteria for the search were determined a priori. No restrictions on the language or date of publication were imposed. The primary author met with a senior author to review the syntax, spelling, and general search strategy to ensure that the search was comprehensive.
Study screening and selection
The targeted studies were included if they met the following inclusion criteria: (1) patients received THA; (2) focused on predictors for DVT. Articles were removed if they met exclusion criteria: (1) abstracts, letters, reviews, or case reports; (2) contained repeated data; (3) posters presented at conferences/congresses; (4) trials without sufficient data to obtain outcomes of interest.
The data included the general characteristics of each study and the outcomes measured. General characteristics included frst author, year of publication, country, the number of patients, and type of article. Two authors performed a systematic screening approach. To maximize the sensitivity of the screen, once disagreements between the two authors at the title, abstract or full-text stages were resolved by consensus decision from a third senior reviewer. The redundant and unrelated records were removed by reading titles and abstracts. Then, the full texts of remainders were downloaded to confrm their eligibility based on above criteria.
Quality assessment
We used the Newcastle Ottawa Quality Assessment Scale (NOQAS) to assess the quality of each study due to retrospective studies. Three points for the quality of participant selection, comparability, exposure, and outcomes in this study. The bias assessment commonly included randomized sequence generation, allocation concealment, performance bias, detection bias, attrition bias, reporting bias, and other biases.
Statistical analysis
Only continuous outcomes were mentioned in our study, so odd ratios (OR) and 95% confidence intervals (CI) were calculated for those outcomes. A p value<0.05 was judged statistically significant. We used random-effects or fixed-effects models according to the heterogeneity of the included studies. Heterogeneity was analyzed with both the Chi squared test (p<0.10) and the I square test (I2>50%). We used Review Manager version 5.3 (The Cochrane Collaboration, Oxford, UK) and STATA 12.0 (Stata Corporation, College Station, TX, USA) to analyze the potential indicators. We used the funnel plot to assess publication bias. We applied Egger and Begg tests to measure the funnel plot asymmetry with a significance level of p<0.10. Because of the low heterogeneity of every factor, we do not calculate sensitive analyses.
Results
Study selection and quality assessment
At first, we collected 53 English articles. Forty-seven articles were excluded due to repetition, inclusion criteria or exclusion criteria, which is shown in Fig. 1. Finally, six English articles, including 270 patients with DVT and 1158 patients without DVT met our inclusion criteria. Table 1 showed the main characteristics of six included English articles (1428 patients) up to October 2023. Three studies scored eight points, and another three scored seven points. Hence, the quality of each study was relatively high. (Table 2).
Age
Five studies [6,7,8,9,10] reported the relationship between age at surgical time and DVT. There was low heterogeneity for age (p for heterogeneity = 0.77, I2 = 0%, Fig. 2). We found that advanced age was a predictor for DVT after THA [fixed-effects model; p<0.00001, OR = 4.51, 95% CI (2.91, 6.10), Fig. 2].
Sex
Six studies [6,7,8,9,10,11] reported the relationship between sex and DVT. There was low heterogeneity for sex (p for heterogeneity = 0.77, I2 = 0%, Fig. 3). We found that female patient was a predictor for DVT after THA [fixed-effects model; p = 0.008, OR = 0.65, 95% CI (0.47, 0.89), Fig. 3].
Body mass index
Five studies [6,7,8,9,10] reported the relationship between body mass index (BMI) and DVT. There was low heterogeneity for BMI (p for heterogeneity = 0.16, I2 = 40%, Fig. 4). We found that BMI was a predictor for DVT after THA [fixed-effects model; p = 0.01, OR = 0.76, 95% CI (0.15, 1.37), Fig. 4].
Diabetes
Four studies [7, 9,10,11] reported the relationship between a history of diabetes and DVT. There was low heterogeneity for diabetes (p for heterogeneity = 0.26, I2 = 25%, Fig. 5). We found that diabetes was a predictor for DVT after THA [fixed-effects model; p = 0.01, OR = 1.85, 95% CI (1.14, 3.01), Fig. 5].
Hypertension
Four studies [6, 7, 9, 10] reported the relationship between a history of hypertension and DVT. There was low heterogeneity for hypertension (p for heterogeneity = 0.91, I2 = 0%, Fig. 6). We found that hypertension was not a predictor for DVT after THA [fixed-effects model; p = 0.10, OR = 1.36, 95% CI (0.94, 1.96), Fig. 6].
Malignancy
Four studies [7, 9,10,11] reported the relationship between a history of malignancy and DVT. There was low heterogeneity for malignancy (p for heterogeneity = 0.92, I2 = 0%, Fig. 7). We found that malignancy was a predictor for DVT after THA [fixed-effects model; p = 0.001, OR = 2.54, 95% CI (1.46, 4.41), Fig. 7].
Smoking
Two studies [10, 11] reported the relationship between a history of smoking and DVT. There was low heterogeneity for smoking (p for heterogeneity = 0.08, I2 = 68%, Fig. 8). We found that smoking was not a predictor for DVT after THA [random-effects model; p = 0.46, OR = 0.37, 95% CI (0.03, 5.11), Fig. 8].
Type of fixation
Two studies [7, 11] reported the relationship between type of fixation and DVT. There was low heterogeneity for type of fixation (p for heterogeneity = 0.08, I2 = 68%, Fig. 9). We found that type of fixation was a risk factor for DVT after THA [fixed-effects model; p = 0.0003, OR = 0.22, 95% CI (0.10, 0.50), Fig. 9].
Operation time
Two studies [6, 7, 9, 10] reported the relationship between operation time and DVT. There was low heterogeneity for operation time (p for heterogeneity = 0.40, I2 = 0%, Fig. 10). We found that longer operation time was a risk factor for DVT after THA [fixed-effects model; p<0.00001, OR = 33.50, 95% CI (23.59, 43.41), Fig. 10].
Hyperlipidemia
Three studies [6, 7, 9] reported the relationship between hyperlipidemia and DVT. There was low heterogeneity for hyperlipidemia (p for heterogeneity = 0.53, I2 = 0%, Fig. 11). We found that hyperlipidemia was not a risk factor for DVT after THA [fixed-effects model; p = 0.27, OR = 1.33, 95% CI (0.80, 2.18), Fig. 11].
White blood cell
Three studies [6, 7, 9] reported the relationship between white blood cell (WBC) and DVT. There was low heterogeneity for WBC (p for heterogeneity = 0.53, I2 = 0%, Fig. 12). We found that WBC was not a risk factor for DVT after THA [fixed-effects model; p = 0.27, OR = 1.33, 95% CI (0.80, 2.18), Fig. 12].
D- dimer
Two studies [8, 9] reported the relationship between D-dimer and DVT. There was high heterogeneity (p for heterogeneity = 0.03, I2 = 80%, Fig. 13). We found that D-Dimer was not a risk factor for DVT after THA [random-effects model; p = 0.76, OR = 0.19, 95% CI (-0.99, 1.36), Fig. 13].
Activated partial thromboplastin time
Two studies [8, 9] reported the relationship between activated partial thromboplastin time (APTT) and DVT. There was low heterogeneity for APTT (p for heterogeneity = 0.58, I2 = 0%, Fig. 14). We found that APTT was not a risk factor for DVT after THA [fixed-effects model; p = 0.96, OR=-0.03, 95% CI (-1.08, 1.03), Fig. 14].
International normalized ratio
Two studies [8, 9] reported the relationship between international normalized ratio (INR) and DVT. There was low heterogeneity for INR (p for heterogeneity = 0.17, I2 = 47%, Fig. 15). We found that INR was not a risk factor for DVT after THA [fixed-effects model; p = 0.83, OR=-0.00, 95% CI (-0.03, 0.02), Fig. 15].
Publication bias
We found no publication bias for all included studies by STATA 12.0 (all P > 0.05).
Discussion
THA, a widely used orthopedic procedure, has adequately improved the holistic function and quality of life in patients with hip diseases [1]. Annually, approximately 30,000 to 50,000 patients received THA in China [12, 13]. However, its derived complications can cause severe functional and psychological disorders, which is a tremendous challenge for orthopedic surgeons. DVT is one of the most common and troublesome complications after THA due to immobilization or medical problems of patients. Early prevention of DVT was beneficial in lowering the incidence of PE [11]. Plasminogen activator inhibitor-1 (PAI-1) was found to be an independent risk factor of DVT after THA [9]. Serum triglyceride levels were found to increase the risk of DVT after THA in female patients [10]. Wong did discover a close relationship between age, gender, race, presence of diabetes, history of malignancy, smoking habit, fixation type, operating time, and DVT [11].
Increasing research has been reported on the predictors of DVT after THA, yet they are still not completely understood. Therefore, the investigation of pointing out the potential indicators related to DVT in patients with THA is urgent. As we know, we are the first to assess the predictors for DVT after THA by meta-analysis. In our study, the rate of DVT was 18.9% (270 of 1428 patients). Our findings showed that advanced age, female patients, BMI, patients with a history of diabetes or malignancy, uncemented prosthesis, and longer operation time were relevant to DVT following THA.
Although previous articles have considered advanced age as an independent risk factor of DVT [14, 15], there remains debate after THA because half of the included articles in this study found no close relationship between age and DVT following THA. Our findings showed that advanced age was an independent predictor of DVT after THA. With the growing age of patients, the elasticity of blood vessels decreases, the blood vessel walls are easily damaged, and elderly patients have increased risks of some diseases closely related to DVT, such as diabetes [16]. Another debated factor was the gender of patients. Our findings indicated that female patients were more likely to suffer from DVT after THA. Two possible elements may account for the gender difference. First, it may be associated with the genetic differences and hormonal changes following menopause and its associated complications [17, 18]. Second, sex differences in DVT may be partially relevant to differing fat metabolism [19, 20]. In terms of BMI, it was larger in the DVT group than in the non-DVT group. Rising BMI was associated with venous thromboembolism due to multiple mechanisms and pathways contributing to this effect [21].
Some primary diseases, such as diabetes, were regarded as independent predictors of DVT based on prior literature [16]. However, there remains controversy in patients following because diabetes was found not to be associated with DVT after THA in half of the included articles. Interestingly, it is a risk factor for DVT after THA in our meta-analysis. It is easy to understand that patients undergoing orthopedic surgery are under stress. Blood glucose fluctuates more frequently in diabetes patients than in non-diabetic patients [22]. During surgery, the body releases various cytokines that rapidly activate the endogenous and exogenous coagulation systems and raise the risk of thrombosis [23]. The findings of this study indicate that blood glucose control in THA patients should be improved during surgery to lower the risk of DVT.
Similarly, we also found that patients with a history of malignancy were prone to suffer from DVT following THA. The potential reason that malignancy can affect various systems of the body can explain this. In the present study, operation time was significantly longer in the DVT group, which can be explained by the two following possible reasons. First, prolonged immobilization could cause venous congestion; second, vascular injury caused by surgery activated the coagulation system. Therefore, shortening surgery during is an effective measure to avoid DVT in patients who underwent THA. Additionally, our findings showed that patients with cemented prostheses tend to have DVT compared with those without it. Intraoperative bone cement can lead to the release of mononuclear cytokines, the separation and deformation of endothelial cells, and the addition of fibrinogen to the endothelial surface, which in turn activates the exogenous blood coagulation pathway, resulting in a high blood coagulation state, thereby increasing the risk of DVT in patients with cemented prostheses [24].
In terms of laboratory tests, D-dimer, which is influenced by numerous variables such as inflammation, age, surgery, hospitalization, COPD, and other acute disorders [25], is commonly utilized to detect DVT. In our research, no significant difference in D-dimer levels was identified between the DVT and non-DVT groups, which contradicted prior findings [14, 26]. Additionally, APTT and INR were also found to have no significant difference in two groups. Elderly patients, blood loss, and operation time surely make patients hypercoagulable in two groups. We still need more included studies to verify these results.
Although there was the first meta-analysis to explore the risk factors of DVT after THA, there were some flaws. First, there was no RCT article focused on this topic; second, due to the small number of included studies, subgroup analysis could not be analyzed, such as type of fixation (cemented vs. uncemented THA; third, most of the included articles originated from Asian countries, which may influence the accuracy of the results.
In summary, advanced age, female patients, BMI, patients with a history of diabetes or malignancy, uncemented prosthesis, and longer operation time were found to be related to DVT after THA. We hope our findings can provide orthopedic surgeons some novel discoveries.
Data availability
No datasets were generated or analysed during the current study.
References
Shapira J, Chen SL, Rosinsky PJ, Maldonado DR, Lall AC, Domb BG. Outcomes of outpatient total hip arthroplasty: a systematic review. Hip Int. 2021;31(1):4–11.
Pedersen AB, Sorensen HT, Mehnert F, Overgaard S, Johnsen SP. Risk factors for venous thromboembolism in patients undergoing total hip replacement and receiving routine thromboprophylaxis. J Bone Joint Surg Am. 2010;92(12):2156–64.
Singh JA. Epidemiology of knee and hip arthroplasty: a systematic review. Open Orthop J. 2011;5:80–5.
Pollock M, Somerville L, Firth A, Lanting B. Outpatient total hip arthroplasty, total knee arthroplasty, and unicompartmental knee arthroplasty: A systematic review of the literature. JBJS Rev. 2016;4(12):01874474–201612000.
Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, et al. Prevention of venous thromboembolism: American college of chest physicians Evidence-Based clinical practice guidelines (8th Edition). Chest. 2008;133(6 Suppl):S381–453.
Yu X, Wu Y, Ning R. The deep vein thrombosis of lower limb after total hip arthroplasty: what should we care. BMC Musculoskelet Disord. 2021;22(1):547. https://doi.org/10.1186/s12891-021-04417-z.
Wakabayashi H, Hasegawa M, Niimi R, Sudo A. Clinical analysis of preoperative deep vein thrombosis risk factors in patients undergoing total hip arthroplasty. Thromb Res. 2015;136(5):855–8.
Hadžimehmedagić A, Rovčanin B, Vranić H, Djedović M, Štraus S, Selimović T. Preoperative femoral vein velocity in maximal flexion is a predictor of deep vein thrombosis in patients undergoing total hip arthroplasty. Acta Clin Croat. 2020;59(3):416–23.
Tang J, Zhu W, Mei X, Zhang Z. Plasminogen activator inhibitor-1: a risk factor for deep vein thrombosis after total hip arthroplasty. J Orthop Surg Res. 2018;13(1):8.
Xu Z, Dai X, Yao Y, Shi D, Chen D, Dai J, Teng H, Jiang Q. Higher levels of serum triglycerides were associated with postoperative deep vein thrombosis after total hip arthroplasty in patients with nontraumatic osteonecrosis of the femoral head. Int J Low Extrem Wounds. 2016;15(1):41–4.
Wong KL, Daguman R, Lim K, Shen L, Lingaraj K. Incidence of deep vein thrombosis following total hip arthroplasty: a doppler ultrasonographic study. J Orthop Surg (Hong Kong). 2011;19(1):50–3.
Tan Z, Cao G, Wang G, Zhou Z, Pei F. Total hospital cost, length of stay, and complications between simultaneous and staged bilateral total hip arthroplasty: A nationwide retrospective cohort study in China. Med (Baltim). 2019;98(11):e14687.
Shi XT, Li CF, Cheng CM, Feng CY, Li SX, Liu JG. Preoperative planning for total hip arthroplasty for neglected developmental dysplasia of the hip. Orthop Surg. 2019;11(3):348–55.
Khan MA, Pal S, Chinoy MA, Ahmed SK. The frequency of deep vein thrombosis in patients with hip fractures. J Pak Med Assoc. 2019;69(1):S21–4.
Xing F, Li L, Long Y, Xiang Z. Admission prevalence of deep vein thrombosis in elderly Chinese patients with hip fracture and a new predictor based on risk factors for thrombosis screening. BMC Musculoskelet Disord. 2018;19(1):444.
Quan Z, Yingyang L. Analysis of the correlative factors infuencing preoperative deep venous thrombosis in elderly patients with hip fractures. China Med Pharm. 2018;8(16):212–4.
Dong Y, Zhong S, Ren Y, Zheng Z. Analysis on risk factors for deep vein thrombosis in patients with traumatic fractures. Chin J Orthop. 2015;35:1077–83.
Roach RE, Cannegieter SC, Lijfering WM. Differential risks in men and women for first and recurrent venous thrombosis: the role of genes and environment. J Thromb Haemost. 2014;12(10):1593–600.
Lima JJ, Mauras N, Kissoon N, Wang J, Wiltrout SA, Sylvester JE. Influence of sex and beta2 adrenergic receptor haplotype on resting and terbutaline-stimulated whole body lipolysis. Metabolism. 2005;54:492–9.
Mittendorfer B. Sexual dimorphism in human lipid metabolism. J Nutr. 2005;135:681–6.
Bawa H, Weick JW, Dirschl DR, Luu HH. Trends in deep vein thrombosis prophylaxis and deep vein thrombosis rates after total hip and knee arthroplasty. J Am Acad Orthop Surg. 2018;26(19):698–705.
Davies HO, Popplewell M, Singhal R, Smith N, Bradbury AW. Obesity and lower limb venous disease - The epidemic of phlebesity. Phlebology. 2017;32(4):227–33.
Wang L, Duan S, Liao D, Luo Z, Hou X. Effect of different use time of intermittent pneumatic compression on the incidence of deep vein thrombosis of lower extremities after arthroplasty. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2020;34(5):585–90.
Mao Y, Ning C, Miaomiao L. Analysis of influencing factors of deep vein thrombosis of lower limbs in elderly patients undergoing hip replacement. J Practical Orthop. 2020;26(1):8–11.
An TJ, Engstrom SM, Oelsner WK, Benvenuti MA, Polkowski GG, Schoenecker JG. Elevated d-dimer is not predictive of symptomatic deep venous thrombosis after total joint arthroplasty. J Arthroplasty. 2016;31:2269–72.
Niu S, Li J, Zhao Y, Ding D, Jiang G, Song Z. Preoperative deep venous thrombosis (DVT) after femoral neck fracture in the elderly, the incidence, timing, location and related risk factors. BMC Musculoskelet Disord. 2021;22(1):264.
Acknowledgements
Not applicable.
Funding
Not applicable.
Author information
Authors and Affiliations
Contributions
TW was responsible for study concept and writing the article. QZ was responsible for screened the abstracts and reviewed the article. ZYH was responsible for reviewing and writing the article.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The study was approved by the Institutional Review Board of The Third Hospital of Hebei Medical University before data collection and analysis. There is no need to write informed consent forms from patients because this is a meta-analysis study.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Wang, T., Zhang, Q. & Hou, Z. Risk factors for deep venous thrombosis following total hip arthroplasty: a meta-analysis. Thrombosis J 23, 58 (2025). https://doi.org/10.1186/s12959-025-00744-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12959-025-00744-6